Author
Listed:
- Clélia Coutzac
(Laboratoire d’Immunomonitoring en Oncologie
Université Paris-Saclay, Faculté de Médicine
Faculté de Médicine
Assistance Publique-Hôpitaux de Paris)
- Jean-Mehdi Jouniaux
(Laboratoire d’Immunomonitoring en Oncologie
Université Paris-Saclay, Faculté de Médicine)
- Angelo Paci
(Vectorologie et thérapeutiques anticancéreuses
Pharmacology and Drug Analysis Department
Faculté de Pharmacie)
- Julien Schmidt
(Laboratoire d’Immunomonitoring en Oncologie
Université Paris-Saclay, Faculté de Médicine)
- Domenico Mallardo
(Instituto Nazionale Tumori- IRCCS –Fondazione G. Pascale)
- Atmane Seck
(Vectorologie et thérapeutiques anticancéreuses
Pharmacology and Drug Analysis Department)
- Vahe Asvatourian
(Biostatistics and Epidemiology Unit
UVSQ, Inserm, CESP)
- Lydie Cassard
(Laboratoire d’Immunomonitoring en Oncologie)
- Patrick Saulnier
(Genomic platform Molecular Biopathology unit and Biological Resource Center)
- Ludovic Lacroix
(Genomic platform Molecular Biopathology unit and Biological Resource Center)
- Paul-Louis Woerther
(Microbiology unit)
- Aurore Vozy
(Laboratoire d’Immunomonitoring en Oncologie)
- Marie Naigeon
(Laboratoire d’Immunomonitoring en Oncologie)
- Laetitia Nebot-Bral
(Université Paris-Saclay, Faculté de Médicine
Stabilité génétique et oncogenèse)
- Mélanie Desbois
(Laboratoire d’Immunomonitoring en Oncologie)
- Ester Simeone
(Instituto Nazionale Tumori- IRCCS –Fondazione G. Pascale)
- Christine Mateus
(Department of Medicine)
- Lisa Boselli
(Laboratoire d’Immunomonitoring en Oncologie)
- Jonathan Grivel
(Laboratoire d’Immunomonitoring en Oncologie)
- Emilie Soularue
(Laboratoire d’Immunomonitoring en Oncologie
Université Paris-Saclay, Faculté de Médicine
Assistance Publique-Hôpitaux de Paris)
- Patricia Lepage
(Micalis Institute)
- Franck Carbonnel
(Université Paris-Saclay, Faculté de Médicine
Assistance Publique-Hôpitaux de Paris)
- Paolo Antonio Ascierto
(Instituto Nazionale Tumori- IRCCS –Fondazione G. Pascale)
- Caroline Robert
(Université Paris-Saclay, Faculté de Médicine
Department of Medicine)
- Nathalie Chaput
(Laboratoire d’Immunomonitoring en Oncologie
Faculté de Pharmacie
Stabilité génétique et oncogenèse)
Abstract
Gut microbiota composition influences the clinical benefit of immune checkpoints in patients with advanced cancer but mechanisms underlying this relationship remain unclear. Molecular mechanism whereby gut microbiota influences immune responses is mainly assigned to gut microbial metabolites. Short-chain fatty acids (SCFA) are produced in large amounts in the colon through bacterial fermentation of dietary fiber. We evaluate in mice and in patients treated with anti-CTLA-4 blocking mAbs whether SCFA levels is related to clinical outcome. High blood butyrate and propionate levels are associated with resistance to CTLA-4 blockade and higher proportion of Treg cells. In mice, butyrate restrains anti-CTLA-4-induced up-regulation of CD80/CD86 on dendritic cells and ICOS on T cells, accumulation of tumor-specific T cells and memory T cells. In patients, high blood butyrate levels moderate ipilimumab-induced accumulation of memory and ICOS + CD4 + T cells and IL-2 impregnation. Altogether, these results suggest that SCFA limits anti-CTLA-4 activity.
Suggested Citation
Clélia Coutzac & Jean-Mehdi Jouniaux & Angelo Paci & Julien Schmidt & Domenico Mallardo & Atmane Seck & Vahe Asvatourian & Lydie Cassard & Patrick Saulnier & Ludovic Lacroix & Paul-Louis Woerther & Au, 2020.
"Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer,"
Nature Communications, Nature, vol. 11(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16079-x
DOI: 10.1038/s41467-020-16079-x
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-020-16079-x. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.